Is Diamyd Medical AB (publ) stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Diamyd Medical AB (publ) 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was SEK7.32, you would have made a profit of SEK5.96 per share or 81.42%
Yes, the average daily trading liquidity for Diamyd Medical AB (publ) is SEK323 150 thousand. You should therefore be able to get in and out of your positions relatively fast.
Diamyd Medical AB (publ) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Diamyd Medical AB (publ) to be high [0.85 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.